Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833
- PMID: 9365166
- PMCID: PMC2228133
- DOI: 10.1038/bjc.1997.530
Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833
Abstract
Inhibition of intestinal P-glycoprotein might enhance the absorption of orally administered P-glycoprotein substrate drugs. We show here a 10-fold increased oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. These results encourage further research on the development of a clinically useful oral formulation of paclitaxel.
Similar articles
-
Oral delivery of taxanes.Invest New Drugs. 2001 May;19(2):155-62. doi: 10.1023/a:1010635000879. Invest New Drugs. 2001. PMID: 11392449 Review.
-
Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.Pharm Res. 2003 Jan;20(1):24-30. doi: 10.1023/a:1022286422439. Pharm Res. 2003. PMID: 12608532
-
P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.Int J Cancer. 2013 May 15;132(10):2439-47. doi: 10.1002/ijc.27912. Epub 2012 Nov 14. Int J Cancer. 2013. PMID: 23090875
-
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.Cancer Chemother Pharmacol. 2002 Apr;49(4):322-8. doi: 10.1007/s00280-001-0419-x. Epub 2002 Feb 1. Cancer Chemother Pharmacol. 2002. PMID: 11914912
-
[SDZ PSC 833: a novel modulator of MDR].Tumori. 1997 Sep-Oct;83(5 Suppl):S21-4. Tumori. 1997. PMID: 9446255 Review. Italian.
Cited by
-
Natural and synthetic polymers as inhibitors of drug efflux pumps.Pharm Res. 2008 Mar;25(3):500-11. doi: 10.1007/s11095-007-9347-8. Epub 2007 Sep 26. Pharm Res. 2008. PMID: 17896100 Free PMC article. Review.
-
The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.Invest New Drugs. 2000 Aug;18(3):231-41. doi: 10.1023/a:1006469621561. Invest New Drugs. 2000. PMID: 10958591 Review.
-
Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.Br J Pharmacol. 1999 May;127(1):43-50. doi: 10.1038/sj.bjp.0702497. Br J Pharmacol. 1999. PMID: 10369454 Free PMC article.
-
Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors.Pharm Res. 2004 Feb;21(2):261-70. doi: 10.1023/b:pham.0000016238.44452.f1. Pharm Res. 2004. PMID: 15032307
-
In vitro intestinal permeability of factor Xa inhibitors: influence of chemical structure on passive transport and susceptibility to efflux.Pharm Res. 2001 Dec;18(12):1735-41. doi: 10.1023/a:1013378731183. Pharm Res. 2001. PMID: 11785694
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources